Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
05/2003
05/13/2003US6563018 Comprising sequence for GAL4 transcription activator and promoter sequence, wherein expression regulatory sequences are integrated in the P-element sequence in such manner that their downstreams are in opposite directions
05/13/2003US6563017 In vivo electroporation method for early stage embryo of chickens
05/13/2003US6563016 Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses
05/13/2003US6563014 Self-contained system for sustained viral replication
05/13/2003US6562593 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/13/2003US6562589 AIB1, a novel steroid receptor co-activator
05/13/2003US6562343 Compositions and methods for the treatment and diagnosis of immune disorders
05/13/2003US6561125 Insect storage and shipping container
05/13/2003CA2467719A1 Anti-il-6 antibodies, compositions, methods and uses
05/08/2003WO2003038124A1 Use of cbg gene as genetic marker of hypercortisolemia and related pathologies
05/08/2003WO2003038104A1 Methods for genetically modifying a target population of an organism
05/08/2003WO2003038062A2 Generation of use of tc1 and tc2 cells
05/08/2003WO2003038058A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
05/08/2003WO2003038052A2 Nucleic acid-associated proteins
05/08/2003WO2003038045A2 Acid phosphatase (acp1) gene as a susceptibility locus for hyperlipidemia
05/08/2003WO2003037932A2 Human coagulation factor vii polypeptides
05/08/2003WO2003037362A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
05/08/2003WO2003037081A1 Hcv gene transgenic animal
05/08/2003WO2003037080A1 Nonhuman model animal of systemic lupus erythematosus
05/08/2003WO2003037079A1 NONHUMAN MODEL ANIMAL OF Th2-MEDIATED HYPERIMMUNE RESPONSE
05/08/2003WO2003037074A2 Methods of generating knock-out rodents
05/08/2003WO2003022228A9 Method for producing transgenic birds and fish
05/08/2003WO2002079230A3 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
05/08/2003US20030088885 Enhanced resolution of tumor metastasis using a skin flap model
05/08/2003US20030088883 Having the reporter gene under operational control of the Colla1 promoter further comprising a regulatory element that regulates the expression of collagen.
05/08/2003US20030088881 Protection of proteins (e.g. fibrinogen) expressed in milk from transgenic animals by co-expression of a serine proteinase inhibitor (e.g. alpha 1-antitrypsin) in the milk of the transgenic animals.
05/08/2003US20030087860 Methods for sexing non-human mammals
05/08/2003US20030087420 Transgenic animals and cells expressing proteins necessary for susceptibility to HIV infection
05/08/2003US20030087384 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment fibroblast growth factor receptor defects
05/08/2003US20030087299 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/08/2003US20030087264 Detection of regulatory response to pulsatile electromagnetic stimulus; obtain tissue sample, insert probe, apply pulsatile stimulus, detect gene expression, classify genes which are expresed
05/08/2003US20030087236 Method for generating diversity
05/08/2003US20030086940 For prophylaxis or therapy of rejection of xenotransplants are
05/08/2003US20030084606 Insect resistance management in agriculture applications
05/08/2003CA2466129A1 Methods for genetically modifying a target population of an organism
05/08/2003CA2465320A1 Use of cbg gene as genetic marker of hypercortisolemia and related pathologies
05/08/2003CA2463091A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
05/08/2003CA2462660A1 Nucleic acid-associated proteins
05/07/2003EP1307560A2 Schizophrenia related gene and protein
05/07/2003EP1307554A2 C3b/c4b complement receptor-like molecules and uses thereof
05/07/2003EP1307552A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF
05/07/2003EP1307482A2 Two coloured fluorimetric protease assay
05/07/2003EP1307225A2 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l
05/07/2003EP1117766A4 Method and apparatus for the storage of entomopathogenic nematodes
05/07/2003EP1029039A4 Non-transgenic animal model of alzheimer's disease
05/07/2003EP1021083B1 A method for increasing incorporation efficiency of omega-3 highly unsaturated fatty acid in poultry meat
05/07/2003EP0872180B1 Medium composition for external fertilization
05/07/2003CN1416318A Oocyte vitrification technique
05/07/2003CN1415196A Method for breeding bethyloids by using yellow flour beetle as interhost
05/07/2003CN1415195A Method for feeding forest beasts and livestock
05/07/2003CN1415194A Method for artificial reproducing crossbred frog
05/07/2003CN1107725C Method for producing anti-pylorospirobacillus immune eggs
05/07/2003CN1107445C Process for preparing transgenosis sheep
05/06/2003US6558932 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
05/06/2003US6558663 Promoting tolerance and inhibiting natural killer cell mediated attack in human recipient to a swine graft
05/06/2003US6557487 Method and device for rearing insects, especially for obtaining a secretion from fly larvae for therapeutic application
05/02/2003EP1306005A1 Nonhuman animal models non-responsive to mycoplasma-origin lipoprotein/lipopeptide
05/02/2003EP1305412A2 Anthozoa derived chromo/fluoroproteins and methods for using the same
05/02/2003EP1305401A2 Pluripotent embryonic stem (es) cell lines, improved methods for their production, and their use for germ line transmission and for the generation of genetically modified animals
05/02/2003EP1304922A2 Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring
05/02/2003EP1304921A2 Transgenic mice containing targeted gene disruptions
05/02/2003EP1304920A2 Transgenic mice containing targeted gene disruptions
05/02/2003EP0986396A4 Prion protein modulator factor (ppmf) and prion resistant animals
05/01/2003WO2003035834A2 Compositions and methods for making mutations in cell lines and animals
05/01/2003WO2003035684A1 Ee3-protein family and corresponding dna sequences
05/01/2003WO2003034818A1 Sgrf genetically modified nonhuman animal
05/01/2003WO2003007701A3 Aquaculture of marine worms
05/01/2003WO2002098444A3 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
05/01/2003WO2001098478A3 Clk-2, cex-7 and coq-4 genes, and uses thereof
05/01/2003WO2000071564A3 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
05/01/2003US20030084471 Methods and compositions for RNA interference
05/01/2003US20030084468 Methods of expressing transgenes
05/01/2003US20030084467 Method for chromosomal rearrangement by consecutive gene targeting of two recombination substrates to the deletion endpoints
05/01/2003US20030084465 Animal is sensitized to selected antigen by administering antigen or nucleic acid encoding antigen; preferred antigens are anaphylactic antigens; sensitized animal can be used to screen for compounds which may help to cure allergies
05/01/2003US20030084463 Method for the production of a protein
05/01/2003US20030083486 Physiologically active protein originating in mammals
05/01/2003US20030083472 Cell surface molecule mediating cell adhesion and signal transmission
05/01/2003US20030083293 Drug delivery of the chromosomes comprising a heterologous DNA to selected cells and tissues; transfection, production of heterologous proteins, gene therapy, generating non-human transgenic animals
05/01/2003US20030082721 Transgenic animals expressing androgen receptor complex-associated protein
05/01/2003US20030082674 Genetically engineered receptor protein for use in the treatment of respiratory system disorders
05/01/2003US20030082672 Dna encoding galanin galr2 receptors and uses thereof
05/01/2003US20030082643 Human monoclonal antibodies to FC alpha receptor (CD89)
05/01/2003US20030082173 Screening drugs that block lymphocytes; genetic engineered rodent
05/01/2003US20030082155 Antidiabetic agents; cell differentiation of stem cells
05/01/2003CA2464344A1 Ee3-protein family and corresponding dna sequences
04/2003
04/30/2003CN2547133Y Ecologic health-care cultivation ornamental garden for pet micro-ant
04/30/2003CN1414975A Sex-chromosome-specific proteins, species specific and sperm specific protein and method for their identification and isolation
04/30/2003CN1414970A Transgenically produced fusion proteins
04/30/2003CN1414091A New technology of culturing cordyceps sinensis using insect
04/30/2003CN1413458A Automatic testing method and system for chicken sex
04/30/2003CN1413457A Goat high-bed shed feeding method
04/29/2003US6555352 Peptide for use in human therapeutics and diagnostic compositions
04/29/2003US6555107 Packaging cell
04/24/2003WO2003033705A1 Transgenic organism expressing fungal mrp-like abc transporters
04/24/2003WO2003033672A2 Nr3b nmda receptor subunit compositions and related methods
04/24/2003WO2003033669A2 Methods for screening and identifying host pathogen defense genes
04/24/2003WO2003032809A2 Modulation of akt-dependent response to prevent restenosis
04/24/2003WO2002072822A3 Als2 gene and amyotrophic lateral sclerosis type 2
04/24/2003WO2002064748A8 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
04/24/2003WO2002059298A9 Gab2(p97) gene and methods of use thereof